CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
Operating cash flow minus capital expenditures
3Y CAGR
+37.9%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.36B | -24.2% |
| 2024 | $1.80B | +78.1% |
| 2023 | $1.01B | +94.2% |
| 2022 | $519.70M | +239.1% |
| 2021 | $-373.59M | -5896.6% |
| 2020 | $-6.23M | - |